Shasta Rayne Harner is the Vice President of Chronic Illness Advocacy and Awareness Group, a patient rights organization that works to promote inclusion of disabled rights and individualized patient-centered care.
She graduated from Sonoma State University with a B.A. in Political Science. She worked for many years as a Certified Medical Assistant and Project Coordinator for a large medical group. In her career, she focused on the delivery of patient care to medical practice administration. Shasta lives with a rare, disabling autoimmune disease called dermatomyositis.
After the onset of her disease, Shasta gained insight into the experience of being a chronically ill patient in today’s medical/political climate. As a result of this experience combined with her work history, personal interests, disability and educational background, she was inspired to advocate for others who also have disabling conditions.
Matt Blahna Senior Manager, Medical Communications
Matt believes that clear communication is critical for ensuring the maximal, appropriate implementation of clinical trial results. After graduate school, Matt left the bench in search of ways to make a greater impact on the lives of patients. He worked for 2 years as a medical writer before joining the Medical Affairs department at Seattle Genetics where he currently oversees scientific communications and publication planning for an investigational tyrosine kinase inhibitor. When not working or chasing after his 2 small kids, Matt enjoys the outdoor cycling and swimming opportunities presented by life in the Pacific northwest.
Iwona Bucior is Director of Medical Communications at Myokardia, responsible for the vision and strategic direction for Medical/Scientific Communications and Publications. She holds a PhD in Biochemistry from the University of Basel in Switzerland, followed by a postdoctoral and specialty fellowships at UCSF, Department of Medicine. Iwona has over 15 years of combined experience in Medical/Scientific Communications and Publications, as well as in Real-World Evidence and Health Economic and Outcomes Research.
Leslie Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences, Editor Emeritus
New York Medical College, International Journal of Clinical Practice
Leslie Citrome, MD, MPH Clinical Professor of Psychiatry and Behavioral Sciences, Editor Emeritus
New York Medical College, International Journal of Clinical Practice
Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation. Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm. Dr. Citrome is the author or co-author of over 500 research reports, reviews, and book chapters in the scientific literature, is on the editorial board of 11 different medical journals, Editor Emeritus at the International Journal of Clinical Practice and where he served as Editor in Chief from 2013 through 2019, reviews for over 75 other journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.
Lisa DeTora Associate Professor and Director of STEM Writing
Lisa DeTora is an Associate Professor and the Director of STEM Writing at Hofstra University where she teaches in various departments and programs including writing studies, rhetoric, disability studies, chemistry, biology, sports science, and narrative medicine. A long-time member of ISMPP’s Ethics and Standards committee, Lisa has co-authored several papers on topics in publication ethics, including authorship, ghostwriting, and everyday tactics for publications management. She has been a speaker at various TIPPA meetings since 2010, covering ethics beyond the ICMJE, authorship, plain language, and translating regulatory materials into publications. Lisa serves as the editor of Regulatory Writing: An Overview, a publication of the Regulatory Affairs Professional Society, which provides guidance and advice for writers of regulatory documentation in CMC, nonclinical, and clinical areas. Her scholarly work also includes studies in embodiment, graphic narrative, technical communication, and the rhetoric of health and medicine.
Ashwini Dhume is the Head of Publications at Taiho Oncology Inc. Dr. Dhume is a highly talented and accomplished biomedical sciences professional with extensive experience in medical communications. She has more than 15 years’ experience in both academia and corporate environments and has worked extensively to establish relationships with patient advocacy groups, corporate partners and scientific collaborators. Dr. Dhume graduated from Creighton University and completed her post-doctoral fellowships at National Institutes of Health and Mount. Sinai School of Medicine before entering the pharmaceutical industry, she can be reached at email@example.com.
As founder and president, Stephen is responsible for the overall leadership of AlphaBioCom and sets the vision and goals for the organization.
A natural leader with a drive for success, with AlphaBioCom Stephen is successfully executing his vision to create the best medical communications company in the industry. Based on a caring culture that strives to deliver a “closest to perfect” level of service
Stephen has led both client and agency teams delivering numerous communications and publication strategies. These include global, US and European.
Stephen has more than 25 years of pharmaceutical and medical communications experience. He has led local operations in the UK and the US for large pharmaceutical companies and directed global communications activities for several brands. In his career, Stephen has managed many multi-billion dollar pharmaceutical assets and been responsible for the launch of many new chemical entities.
Brian Falcone is the Executive Vice President of Oxford PharmaGenesis Inc. Brian has 13 years of experience in medical communications, which includes both publications and various non-publications activities such as advisory boards, competitive intelligence, marketplace forecasting, and strategic communication and marketing planning. Brian obtained his PhD in organic chemistry from Princeton University and performed his postdoctoral fellowship at Johnson and Johnson Pharmaceutical Research and Development.
Lynne Gordon, MPH, CMPP™ Senior Director, Scientific Publications and Medical Affairs
Lynne has worked in the pharmaceutical industry for over 25 years, in both large pharma and start-up biotech companies. She was a field-based Medical Science Liaison (MSL) for 15 years and has been in-house at Theravance Biopharma US, Inc. for the past 9 years. In her current role, she is the sole publication professional and manages all things relating to publications for the four compounds in various stages of development, from Phase 1 to a commercialized product. Her other responsibilities include Medical Affairs operations such as departmental policies, guidelines and work instructions.
Amanda Greene is a passionate healthcare activist. She is living with lupus and other autoimmune conditions, as well as fibromyalgia, osteoarthritis and rheumatoid arthritis. Her struggles made her advocate for herself and now she advocates for others. In 2019, Amanda served as a Patient Leader Advisory Board after winning the WEGO Health Award for Healthcare Collaborator: Patient. During Lupus Awareness Month, the Lupus Research Alliance recognized Amanda as a “Lupus Luminary: This year, Amanda will be speaking at the Virtual Medicine Conference and leading a session during the HealtheVoices 2020 Patient Advocacy Conference and advocating on Capitol Hill for Lupus Research this Spring. Amanda engages actively online, find her on Twitter as @LAlupusLady and Instagram as @msamandagreene.
As Chief Executive Officer of Within3, Lance Hill brings his own brand of energy, leadership and vision to the company.
With the belief that deeper engagement among healthcare professionals results in improved healthcare and better patient outcomes, Lance strategizes with global healthcare decision makers on how to integrate digital collaboration solutions into their businesses as an effective new channel of communication.
Prior to joining Within3, Lance served as the Vice President and General Manager of the worldwide Service Oriented Architecture business unit for the webMethods Corporation, an international leader in enterprise software. With annual revenues exceeding $200 million, webMethods was acquired in 2007 by German giant, Software AG, for $546 million.
Recruited directly from the University of Toledo by tech giant IBM, Lance led the design and implementation of global telecommunication networks for Fortune 500 businesses and major healthcare organizations, as well as consulted and lectured on worldwide technology strategies. He also developed training, methodology and best practices for Global Services consultants. Lance subsequently joined a top 10 U.S. financial services firm where he served as the Vice President of Enterprise Engineering and founded its Fusion Technology Group, dedicated to accelerating corporate adoption of new technologies and business processes.
A veteran in the technology industry, Lance dedicates himself to work he strongly believes in — improving healthcare by providing an easy-to-use, always accessible, digital collaboration solution for healthcare professionals and industry leaders to connect, communicate and collaborate.
Burnedette Rose Hill
Deputy Director, Scientific & Medical Publications
Burnedette Rose Hill Deputy Director, Scientific & Medical Publications
Burnedette Rose Hill is a global strategic communications and marketing operations business partner, recognized for her outstanding ability to build and maintain valued stakeholder relations. Her primary areas of expertise are Strategic Communications, Thought Leader engagement, Advisory Boards, Speaker Program Operations and healthcare compliance in 'Big Pharma' and start-up life science companies.
Finding alternatives to traditional approaches, methods and solutions and exploring problems thoroughly from multiple perspectives before taking action, have gained Burnedette respect from colleagues and clients who rely on her talent as a “connector”.
Val Injev, MBA, P.E. Global Medical Publications Lead
Alcon Vision LLC
Val has been working in the Medical Device industry for over 30 years. He has spent over 25 years in various R&D capacities and currently Leads the Global Medical Publications for the Surgical Franchise, which includes implantable devices, surgical equipment and accessories, lasers, diagnostic devices, surgical microscopes etc. Val has been actively involved in the development of hundreds of journal and congress publications. In addition to his publications experience, he has expertise in product development and use of ophthalmic devices, and is a holder of over a dozen device patents. Val has an MBA and a Bachelor of Science degree in Mechanical Engineering, both from the University of California, Irvine and is a Certified Engineer (PE) in the State of California.
Dr. Meghan Jendrysik is currently Managing Editor of the journal Biomedicine & Pharmacotherapy. She has held a variety of positions during her eight+ years in Elsevier’s Kendall Square office, including Scientific Editor of GENE and the Journal of Molecular Biology, Editorial Manager of the journal Carbohydrate Polymers, and Publisher of Elsevier’s portfolio of toxicology journals. She has experience managing and launching both Open Access and traditional subscription-based journals. Dr. Jendrysik has a strong interest in the ethics of scientific publishing, especially the disclosure of potential conflicts of interest and the integrity of the peer review process. Prior to joining Elsevier, she held a Post-Doctoral Research Fellowship at the National Institute of Allergy and Infectious Diseases/National Institutes of Health in Bethesda, MD. She holds a bachelor’s degree in biology from MIT, and a PhD in pathology from the University of Illinois at Chicago. Her research experience includes investigating the role of dendritic cells in HIV transmission and the role of the NADPH oxidase enzymes in regulating the immune response. She is a Vice-President of the MIT Club of Boston, and recently completed a Master’s degree in the History of Science, Technology and Medicine at the Harvard Extension School.
For over 30 years, Gordon has acquired significant experience in medical communications including the strategic team leadership of global accounts, requiring extensive knowledge of pharmaceutical marketing/medical communications at an international level. Over the years, he been personally involved in the development and implementation of multiple medical communication plans, with education, publication, KOL engagement and advocacy components. Gordon set up Porterhouse Medical US at the end of 2017. The award-winning Porterhouse Medical Group comprises medical communications, market research and insights professionals, with offices in the UK and the USA. We work with clients across the globe to generate insight and develop creative, scientific and medical communications with maximum impact.
Established with that objective in mind, Porterhouse Medical US offers our clients ready access to the group’s network of experts and suite of services. These include medical writing, publication planning and implementation, communication strategy development, market research and insights, creative services, event management, health economics and market access. These services are delivered by experienced medical communications professionals from a variety of disciplines, including scientific solutions, client and creative services, and event facilitation.
With particular expertise in publication planning, Gordon is actively involved in both ISMPP (as a Charter Member, and long-time member of the Ethics and Best Practice Committee) and previous faculty member at TIPPA on several occasions.
Susan Nastasee, MS, ISMPP CMPP Associate Director, Publication Advisor
Susan Nastasee, MS, ISMPP CMPP, has more than 20 years’ experience as a publication professional. Susan is currently Associate Director, Publication Advisor at Bristol-Myers Squibb, where she develops publication policy and guidelines, and provides training and subject matter expertise to internal colleagues and agency partners involved in publication planning and development. Prior to this role, Susan was a medical writer supporting virology and immunoscience at Bristol-Myers Squibb and Wyeth. Susan is an ISMPP-certified medical publication professional (CMPP), having served for several years on the ISMPP Ethics Committee and the Standards Working Group. She has been an author and presenter on multiple ISMPP presentations, and has served as a Roundtable moderator during ISMPP annual meetings. Susan is also a steering committee member of Medical Publishing Insights and Practices (MPIP).
Shweta Rane, PhD, ISMPP CMPP Director of Global Scientific Communications
Alexion Pharmaceuticals, Inc.
Shweta Rane, PhD, ISMPP CMPP, is the Director of Global Scientific Communications at Alexion Pharmaceuticals, with over 16 years of combined experience (academia and industry) in R&D and medical affairs. She started in R&D as a Senior Scientist at GlaxoSmithKline (GSK) and then transitioned to medical/scientific communications. Prior to joining Alexion Pharmaceuticals, she held positions with increasing responsibilities at Takeda Pharmaceuticals, Mallinckrodt Pharmaceuticals, and GSK. She is a seasoned medical/scientific communications professional working on pre- and post-launch products from both regional and global perspectives, including working under a corporate integrity agreement.
Dr. Rane has an extensive experience across multiple therapeutic areas including cardiovascular diseases, gastroenterology, hematology, immunology, neurogastroenterology, neurology, post-transplant medications, psychiatry, and respiratory disorders. Recently, she has been leading medical & scientific communications strategies in orphan/rare and ultra-rare disease portfolios.
Dr. Rane is an active member of ISMPP (with CMPP certification) serving on the CMPP Recertification and CMPP exam writing committees. She is also a member of Healthcare Businesswomen’s Association (HBA) and is currently the Director at Large – Programming for the HBA-Boston Chapter.
Dr. Rane received her Bachelor of Engineering (Biomedical) degree from Mumbai University, her MS in Cell and Molecular Biology from Long Island University, and her PhD in Cell and Molecular Medicine from the University of Medicine and Dentistry of New Jersey (now Rutgers New Jersey Medical School). She has also earned a mini-MBA from Rutgers University.
Samantha Rose Senior Manager of Global Medical Communications
Samantha Rose is a Senior Manager of Global Medical Communications at Allergan in Madison, New Jersey. In her current role, she leads publication planning, strategy and execution for the portfolio of retina-related products. Previous roles include management of locally-developed publications at Bristol-Myers Squibb and client services program management at ApotheCom, a medical communications agency. She is an ISMPP-certified medical publication professional (CMPP) and an active member of ISMPP currently serving on the CMPP Recertification Committee. She has a bachelor of science from The College of New Jersey and is currently pursuing an MBA at Fairleigh Dickinson University.
Wendi obtained her B.S. in Zoology from Washington State University and her Master’s in Pharmacology and Toxicology from Michigan State University. Wendi has over 17 years of experience in the biotechnology/healthcare industry including 12 years (and counting) with Seattle Genetics. At Seattle Genetics, Wendi manages company- and investigator-led publications and develops strategic scientific communications for the company’s breast cancer portfolio and multiple early-stage development programs. Wendi recently coordinated efforts for a simultaneous manuscript publication in NEJM and primary data presentation at the San Antonio Breast Cancer Symposium. In her spare time, Wendi enjoys cooking, traveling, and spending time with her friends and family.
Chirag Shah, PharmD, RPh Strategic Publications & Medical Education Lead
Chirag Shah currently leads the independent medical education and strategic publication planning group at Neurocrine Biosciences.
Chirag has a strong background in Medical Affairs including medical communication, medical information, and project management. He received his PharmD from the Philadelphia College of Pharmacy and has worked at organizations of varying sizes and therapeutic areas including Sunovion, Mallinckrodt, Teva, Receptos-Celgene, and Arena. Chirag is an outdoor enthusiast, and on the weekends you can find him hiking or biking the coast!
Senior Medical Writer, Science Communications and Publications
Aparna Shetty Senior Medical Writer, Science Communications and Publications
Aparna Shetty is a senior medical writer in the Scientific Communications team at Natera, Inc. She is a trained scientist and obtained her PhD in neuroscience at the University of Hamburg, Germany. She continued with her research training as a postdoc at the University of Zurich and the University of California, San Francisco, before transitioning to scientific writing. Aparna is passionate about scientific communciatons and has worked at several medical agencies before joining Natera. At Natera, she manages publications related to women's health and transplant. She often volunteers at organizations related to science outreach and education and enjoys mentoring aspiring scientists.
Donna Simcoe, MS, MS, MBA, CMPP Medical Publication Consultant
Donna is a Medical Publications consultant and principal at Simcoe Consultants, Inc., a biomedical company focusing on medical publication development and medical writing. Donna Simcoe has managed publications for 25+ years at Cadence, AstraZeneca, Wyeth, and Cephalon. Donna holds 3 Master degrees in Biomedical Writing, Biotechnology, and an MBA, and is a Certified Medical Publication Professional (CMPP). She is an active member of the American Medical Writers Association (AMWA), the International Society of Medical Publication Professions (ISMPP) and The International Publication Planning Association (TIPPA). Donna has led or is a member of ISMPP committees, teaches as part of the University of California San Diego (UCSD) Extension Medical Writing Certificate program, and is Past-President of the AMWA Pacific Southwest Chapter.
Kelly Soldavin is a Medical Editor for the publisher Taylor & Francis and a member of their London-based Medicine & Health Editorial team. In this role, Kelly manages Current Medical Research & Opinion, a MEDLINE-indexed, peer-reviewed, international journal for the publication of original research on new and existing drugs, Phase II through IV studies, and post-marketing investigations. She also manages Journal of Drug Assessment, an official publication of the National Association of Specialty Pharmacy, and previously managed Journal of Medical Economics. Kelly is an advocate for, and has a special interest in, open science and ethical and transparent publishing, as well as patient engagement and plain language summaries. She has spoken on these topics for the International Publication Planning Meeting (TIPPA), International Society for Medical Publication Professionals (ISMPP), and Special Libraries Association (SLA). In addition, Kelly is a member of the ISMPP Social Media & Web-based Metrics Working Group. Prior to joining T&F, Kelly spent 14 years in the veterinary medicine publishing industry. She works in Philadelphia and received her Bachelor of Science degree from Delaware Valley University, Doylestown, Pennsylvania.
Jamie Weiss, PhD
Associate Director of US Neuroscience Publications
Jamie Weiss, PhD Associate Director of US Neuroscience Publications
Jamie Weiss is an Associate Director, US Neuroscience Publications, Medial Affairs Communications, Clinical Development and Medical Affairs, Novartis, East Hanover, NJ. Jamie has worked in the pharmaceutical industry for 9 years; Hoffman La-Roche (oncology, immunology) and Pfizer (Wyeth; CNS) as a researcher. She was a professor of biomedical science, teaching courses in pharmacology, neuroscience, cell biology and anatomy/physiology, and a principal investigator running a research laboratory in cellular/molecular neurobiology and physiology for over 11 years. She is an experienced workshop leader and course facilitator having delivered training programs and teaching at all levels from kindergarten to high school students, and undergraduate/graduate students to experienced physicians.
She has been writing in the biomedical science field for over 18 years and has numerous peer-reviewed scientific articles published. Prior to joining Novartis, Jamie worked at Allergan, Bridgewater, NJ, as a senior medical writer in eye care, publications. Jamie has a Bachelor of Arts in biological science (genetics-cellular and molecular biology) from Rutgers College, Rutgers University and a PhD in neuroscience (cellular and molecular) from Iowa State University.
Candice Willmon Associate Director, Medical Communications, Medical Affairs
Candice Willmon is a scientist, writer, music enthusiast, globe trotter, and striving golf pro, who supports her varied interests as an Associate Director of Medical Communications at Seattle Genetics. After the loss of a friend in high school, Candice devoted her life to the development of novel therapeutics for patients with cancer. She received her PhD in Pharmacology/Toxicology from Washington State University and did her postdoctoral fellowship in the Molecular Medicine Department at Mayo Clinic. In 2010, Candice transitioned from the bench to Medical Communications where she has leveraged her oncology expertise and writing skills in both the Medical and Commercial realms. She currently leads a talented group of people in developing the scientific communication strategy for approved and pipeline targeted oncology therapeutics at Seattle Genetics.